Market closed
Charles River/$CRL
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Charles River
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Ticker
$CRL
Sector
Trading on
NYSE
Industry
Life Sciences Tools & Services
Headquarters
Employees
21,100
Website
Charles River Metrics
BasicAdvanced
$9.5B
Market cap
23.22
P/E ratio
$8.00
EPS
1.38
Beta
-
Dividend rate
Price and volume
Market cap
$9.5B
Beta
1.38
52-week high
$275.00
52-week low
$176.48
Average daily volume
640K
Financial strength
Current ratio
1.477
Quick ratio
0.953
Long term debt to equity
72.092
Total debt to equity
72.092
Interest coverage (TTM)
4.54%
Management effectiveness
Return on assets (TTM)
5.12%
Return on equity (TTM)
11.92%
Valuation
Price to earnings (TTM)
23.215
Price to revenue (TTM)
2.352
Price to book
2.51
Price to tangible book (TTM)
-78.65
Price to free cash flow (TTM)
17.044
Growth
Revenue change (TTM)
-3.67%
Earnings per share change (TTM)
-13.25%
3-year revenue growth (CAGR)
5.83%
3-year earnings per share growth (CAGR)
1.20%
What the Analysts think about Charles River
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Charles River stock.
Charles River Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Charles River Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Charles River News
AllArticlesVideos
Charles River Laboratories International, Inc. (CRL) Q3 2024 Earnings Call Transcript
Seeking Alpha·1 month ago
Charles River Laboratories raises annual profit forecast on stabilizing biotech demand
Reuters·2 months ago
Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call
Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Charles River stock?
Charles River (CRL) has a market cap of $9.5B as of December 22, 2024.
What is the P/E ratio for Charles River stock?
The price to earnings (P/E) ratio for Charles River (CRL) stock is 23.22 as of December 22, 2024.
Does Charles River stock pay dividends?
No, Charles River (CRL) stock does not pay dividends to its shareholders as of December 22, 2024.
When is the next Charles River dividend payment date?
Charles River (CRL) stock does not pay dividends to its shareholders.
What is the beta indicator for Charles River?
Charles River (CRL) has a beta rating of 1.38. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.